Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Prepaid Assets: 2010-2021

Historic Prepaid Assets for Neurocrine Biosciences (NBIX) over the last 10 years, with Sep 2021 value amounting to $50.5 million.

  • Neurocrine Biosciences' Prepaid Assets rose 45.53% to $50.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $50.5 million, marking a year-over-year increase of 45.53%. This contributed to the annual value of $30.1 million for FY2020, which is 81.33% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Prepaid Assets stood at $50.5 million, which was up 31.51% from $38.4 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Prepaid Assets high stood at $50.5 million for Q3 2021, and its period low was $3.9 million during Q1 2017.
  • Moreover, its 3-year median value for Prepaid Assets was $27.5 million (2020), whereas its average is $29.7 million.
  • In the last 5 years, Neurocrine Biosciences' Prepaid Assets dropped by 11.56% in 2017 and then spiked by 194.65% in 2018.
  • Neurocrine Biosciences' Prepaid Assets (Quarterly) stood at $6.8 million in 2017, then surged by 171.88% to $18.6 million in 2018, then declined by 10.72% to $16.6 million in 2019, then surged by 81.33% to $30.1 million in 2020, then soared by 45.53% to $50.5 million in 2021.
  • Its last three reported values are $50.5 million in Q3 2021, $38.4 million for Q2 2021, and $33.8 million during Q1 2021.